Company intelligence / Profile preview

Melio Bio

Oxford, Oxfordshire, United Kingdommelio.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

Melio Bio has developed a rapid diagnostic platform capable of identifying over 99% of common bloodborne pathogens within hours, targeting critical needs such as neonatal sepsis. The company also has an early-stage therapeutic pipeline focused on small molecule drugs targeting GPR75 for obesity. Recent funding from CARB-X supports further development of their diagnostics. The company won the Pioneer/Novo Nordisk Golden Ticket to accelerate its metabolic disease drug discovery efforts.

Therapeutic areas: Metabolic DisordersInfectious Diseases
Modalities: Small molecules (for obesity/metabolic programs)Diagnostic platforms integrating assays, microfluidics, and machine learning for pathogen detection
Industry: Biotech

Partnerships

Sygnature Discovery (drug discovery partnership on GPR75 program)CARB-X funding partnership on diagnostics development.Novo Nordisk/Pioneer Group Golden Ticket winner provides industry support/lab space access.

Beyond the preview

Go deeper on Melio Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melio Bio.

Explore the full profile